|
Originally published In Press as doi:10.1074/jbc.M201378200 on April 30, 2002
J. Biol. Chem., Vol. 277, Issue 28, 25697-25702, July 12, 2002
Expression of the Human Poliovirus
Receptor/CD155 Gene Is Activated by Sonic Hedgehog*
David J.
Solecki §,
Matthias
Gromeier ¶,
Steffen
Mueller ,
Günter
Bernhardt** , and
Eckard
Wimmer
From the Department of Molecular Genetics and
Microbiology, School of Medicine, State University of New York at Stony
Brook, Stony Brook, New York 11794 and
** Max-Delbrück-Centrum für Molekulare Medizin,
Robert-Rössle-Strasse 10, 13092 Berlin, Germany
The human poliovirus receptor/CD155 is a
transmembrane glycoprotein belonging to the immunoglobulin superfamily.
The ectodomain of CD155 mediates cell attachment to the extracellular
matrix molecule vitronectin, while its intracellular domain
interacts with the dynein light chain Tctex-1. CD155 is a
primate-restricted gene that is expressed during development in
mesenchymal tissues and ventrally derived structures within the
CNS. Its function in adults is as yet unknown, but
significantly, CD155 is aberrantly expressed in neuroectodermal tumors.
We show that the expression of CD155 mRNA is
up-regulated when human Ntera2 cells are treated with purified Sonic
hedgehog (Shh) protein. Reporter gene expression driven by the
CD155 core promoter is activated by Shh in transient co-transfection assays. Analysis of the CD155 core promoter
indicates that an intact GLI binding site is required for Shh
activation. In addition, overexpression of Gli1 or
Gli3 potently activates reporter gene expression driven by
the CD155 core promoter. These data identify the
CD155 gene as a transcriptional target of Shh, a finding
that has significance for the normal function of CD155 during
development and the expression of CD155 in neuroectodermal tumors.
*
This work was supported in part by National Institutes of
Health Grant AI39485 (to E. W.).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
A member of the graduate program in Molecular and Cellular Biology,
State University of New York at Stony Brook and recipient of a grant
from the Deutscher Akademischer Austauschdienst (DAAD). To whom
inquiries should be addressed: Laboratory of Developmental Neurobiology, The Rockefeller University, 1230 York Ave., New York, NY
10021. E-mail: soleckd@mail.rockefeller.edu.
¶
Recipient of a Burroughs Wellcome Career Award. Current
address: Dept. of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, NC 27710.
Supported by a doctoral fellowship of BoehringerIngelheim
Fonds, Heidesheim, Germany.

Supported by Grant BE1886/1-2 from the Deutsche Forschungsgemeinschaft.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. Ochiai, S. A. Campbell, G. E. Archer, T. A. Chewning, E. Dragunsky, A. Ivanov, M. Gromeier, and J. H. Sampson
Targeted Therapy for Glioblastoma Multiforme Neoplastic Meningitis with Intrathecal Delivery of an Oncolytic Recombinant Poliovirus
Clin. Cancer Res.,
February 15, 2006;
12(4):
1349 - 1354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Boles, W. Barchet, T. Diacovo, M. Cella, and M. Colonna
The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM
Blood,
August 1, 2005;
106(3):
779 - 786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ochiai, S. A. Moore, G. E. Archer, T. Okamura, T. A. Chewning, J. R. Marks, J. H. Sampson, and M. Gromeier
Treatment of Intracerebral Neoplasia and Neoplastic Meningitis with Regional Delivery of Oncolytic Recombinant Poliovirus
Clin. Cancer Res.,
July 15, 2004;
10(14):
4831 - 4838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Merrill, G. Bernhardt, J. H. Sampson, C. J. Wikstrand, D. D. Bigner, and M. Gromeier
Poliovirus receptor CD155-targeted oncolysis of glioma
Neuro-oncol,
July 1, 2004;
6(3):
208 - 217.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mueller and E. Wimmer
Recruitment of Nectin-3 to Cell-Cell Junctions through trans-Heterophilic Interaction with CD155, a Vitronectin and Poliovirus Receptor That Localizes to {alpha}v{beta}3 Integrin-containing Membrane Microdomains
J. Biol. Chem.,
August 15, 2003;
278(33):
31251 - 31260.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|